Abbvie finalizes deal to buy Botox maker Allergan for $63 billion Medical Dialogues Bureau26 Jun 2019 10:00 AM ISTA note from Moody's affirmed Abbvie's debt rating, saying a plan to reduce debt through existing blockbusters like AbbVie's Humira and Imbruvica and...
GSK, Pfizer gets CCI approval for consumer healthcare JV formation Garima25 May 2019 9:45 AM ISTAfter the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business, while Pfizer will...
Pfizer acquires clinical-stage Biotech Therachon for $810 million Garima12 May 2019 9:45 AM ISTNEW YORK: Pfizer recently announced that it has entered into a definitive agreement to acquire all the shares of Therachon Holding AG, a privately...
Pfizer gets USFDA nod for potential blockbuster heart drug Tafamidis Medical Dialogues Bureau7 May 2019 9:45 AM ISTPfizer, which has touted tafamidis as a potential blockbuster product, set a list price of $225,000 a year for the medicine, which would be sold under...
Novartis to face lawsuit over doctor kickbacks Garima3 April 2019 9:10 AM ISTThe case began in 2011 as a whistleblower lawsuit filed by Oswald Bilotta, a former Novartis sales representative. Such lawsuits, brought under the...
New York City launches $100 million universal health insurance program Medical Dialogues Bureau9 Jan 2019 9:00 AM ISTNEW YORK: New York City recently launched a $100 million health insurance program to cover 600,000 uninsured city residents, including those unable to...
